SPRO

Spero Therapeutics Inc

May 20 • 04:00PM ET

2.63

+0.04 1.54 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: SCYX INO OCGN VIR CERS

| Held by: VTI VXF QQQS DFAS AVSC PRFZ DCOR DFAT DFAC

Scroll to Statements

Index	-	P/E	10.79	EPS (ttm)	0.24	Insider Own	25.86%	Shs Outstand	57.89M	Perf Week	7.79%
Market Cap	152.28M	Forward P/E	3.46	EPS next Y	0.76	Insider Trans	-1.30%	Shs Float	42.93M	Perf Month	-6.07%
Enterprise Value	98.62M	PEG	-	EPS next Q	-	Inst Own	14.47%	Short Float	2.75%	Perf Quarter	9.58%
Income	15.23M	P/S	2.78	EPS this Y	346.67%	Inst Trans	0.98%	Short Ratio	2.69	Perf Half Y	8.23%
Sales	54.77M	P/B	2.88	EPS next Y	13.43%	ROA	22.28%	Short Interest	1.18M	Perf YTD	12.88%
Book/sh	0.91	P/C	2.71	EPS next 5Y	-	ROE	35.12%	52W High	3.22 -18.32%	Perf Year	286.65%
Cash/sh	0.97	P/FCF	21.03	EPS past 3/5Y	- -	ROIC	28.51%	52W Low	0.66 300.79%	Perf 3Y	42.16%
Dividend Est.	-	EV/EBITDA	12.71	Sales past 3/5Y	7.06% 197.00%	Gross Margin	-	Volatility	8.16% 5.44%	Perf 5Y	-81.48%
Dividend TTM	-	EV/Sales	1.80	EPS Y/Y TTM	121.50%	Oper. Margin	14.16%	ATR (14)	0.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.50	Sales Y/Y TTM	93.50%	Profit Margin	27.82%	RSI (14)	51.81	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.50	EPS Q/Q	49.76%	SMA20	1.54%	Beta	1.43	Target Price	4.00
Payout	0.00%	Debt/Eq	0.05	Sales Q/Q	-94.95%	SMA50	2.02%	Rel Volume	0.73	Prev Close	2.59
Employees	25	LT Debt/Eq	0.01	Earnings	May 13 AMC	SMA200	13.05%	Avg Volume	438.60K	Price	2.63
IPO	Nov 02, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	319,553	Change	1.54%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)